These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23883545)

  • 21. An International Atherosclerosis Society position paper: global recommendations for the management of dyslipidemia: executive summary.
    Expert Panel on Dyslipidemia
    Atherosclerosis; 2014 Feb; 232(2):410-3. PubMed ID: 24468156
    [No Abstract]   [Full Text] [Related]  

  • 22. [Guideline for hyperlipidemia].
    Seishima M
    Rinsho Byori; 2003 Jun; 51(6):576-80. PubMed ID: 12884746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving the prevention of cardiovascular disease.
    Hainsworth T
    Nurs Times; 2006 Feb 14-20; 102(7):23-4. PubMed ID: 16512042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Guidelines for the management of atherosclerotic diseases in diabetes mellitus].
    Kotake H; Oikawa S
    Nihon Rinsho; 2006 Nov; 64(11):2074-80. PubMed ID: 17087299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Proposal for the Optimal Management Target for Serum Non-High-Density Lipoprotein Cholesterol Level in Low-Risk Japanese Workers.
    Saiki Y; Otsuka T; Kato K; Kawada T
    J Atheroscler Thromb; 2016; 23(4):422-30. PubMed ID: 26875520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Merits and potential downsides of the 2013 ACC/AHA cholesterol management guidelines.
    Gotto AM; Moon JE
    Nutr Metab Cardiovasc Dis; 2014 Jun; 24(6):573-6. PubMed ID: 24819819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comment on the 2013 ACC/AHA guidelines on Lifestyle Management to Reduce Cardiovascular Risk by the JAS Guidelines Committee.
    Koba S; Maruyama C; Sasaki J
    J Atheroscler Thromb; 2014; 21(5):375-7. PubMed ID: 24747155
    [No Abstract]   [Full Text] [Related]  

  • 28. [New European guidelines for cardiovascular prevention].
    Wilhelmsen L; Perk J
    Lakartidningen; 2004 Nov; 101(46):3677-8, 3680-2. PubMed ID: 15586492
    [No Abstract]   [Full Text] [Related]  

  • 29. [The new 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk: comparison with the ESC/EAS recommendations for the management of dyslipidemias].
    Catapano AL; Averna M; Faggiano P; Novo S
    G Ital Cardiol (Rome); 2014 Jan; 15(1):19-20. PubMed ID: 24503730
    [No Abstract]   [Full Text] [Related]  

  • 30. [Recommendations for the prevention of cardiovascular diseases in clinical practice].
    De Backer G; De Bacquer D; Brohet C; De Ceukelier S; Franck A; Krzentowsky G; Legat P; Pochet JM; Scheen A;
    J Pharm Belg; 2005; 60(2):41-50. PubMed ID: 16035368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Guidelines for the prevention and treatment of atherosclerosis and cardiovasculer diseases: treatment of diabetes mellitus, dyslipidemia and the prevention of stroke].
    Bitzur R; Harats D; Rubinstein A
    Harefuah; 2005 Sep; 144(9):647-54, 675. PubMed ID: 16218538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statins for Primary Prevention of Cardiovascular Disease: Review of Evidence and Recommendations for Clinical Practice.
    Kazi DS; Penko JM; Bibbins-Domingo K
    Med Clin North Am; 2017 Jul; 101(4):689-699. PubMed ID: 28577620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Achievement rates of Japan Atherosclerosis Society Guidelines 2007 LDL-cholesterol goals with rosuvastatin or atorvastatin in patients who had not achieved their goal with atorvastatin.
    Shioji K; Izuhara M; Mitsuoka H; Uegaito T; Matsuda M;
    Cardiovasc Ther; 2014 Jun; 32(3):97-104. PubMed ID: 24456217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive risk management for the prevention of cerebro- cardiovascular diseases in Japan.
    Joint Committee for Comprehensive Risk Management Chart for the Prevention of Cerebro- Cardiovascular Diseases
    Hypertens Res; 2017 Oct; 40(10):847-855. PubMed ID: 28701740
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prevention and treatment of atherosclerosis and cardiovascular diseases].
    Knobler H; Bitzur R; Gavish D; Rubinstein A; Henkin Y; Chajek-Shaul T; Harats D
    Harefuah; 2012 May; 151(5):281-8, 319, 318. PubMed ID: 22844732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Report of the Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese adults.
    Hata Y; Mabuchi H; Saito Y; Itakura H; Egusa G; Ito H; Teramoto T; Tsushima M; Tada N; Oikawa S; Yamada N; Yamashita S; Sakuma N; Sasaki J;
    J Atheroscler Thromb; 2002; 9(1):1-27. PubMed ID: 12238634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2016 Consensus statement on prevention of atherosclerotic cardiovascular disease in the Hong Kong population.
    Cheung BM; Cheng CH; Lau CP; Wong CK; Ma RC; Chu DW; Ho DH; Lee KL; Tse HF; Wong AS; Yan BP; Yan VW
    Hong Kong Med J; 2017 Apr; 23(2):191-201. PubMed ID: 28387202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cardiovascular risk factors and prevention].
    Bongard V; Ferrières J
    Rev Prat; 2006 Jan; 56(1):79-87, 94. PubMed ID: 16548253
    [No Abstract]   [Full Text] [Related]  

  • 39. Comprehensive Risk Management for the Prevention of Cerebro- Cardiovascular Diseases in Japan.
    Joint Committee for Comprehensive Risk Management Chart for the Prevention of Cerebro- Cardiovascular Diseases
    J Atheroscler Thromb; 2017 Jul; 24(7):749-764. PubMed ID: 28652526
    [No Abstract]   [Full Text] [Related]  

  • 40. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
    Bruckert E; Ferrières J
    Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.